Skip to content
ppharmaranks
Menu
Class IIIOngoing

Ciclopirox Gel 0.77% recall

FDA recall D-0002-2025 · initiated Sep 30, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Oct 9, 2024How we research

Glenmark Pharmaceuticals Inc., USA recalled Ciclopirox Gel 0.77% in Sep 2024 — an FDA Class III recall (D-0002-2025) because Defective Container: Firm received complaints of broken tube at the seal.

Unlikely to cause harm but violates FDA labeling or manufacturing regulations.

Why it was recalled

Defective Container: Firm received complaints of broken tube at the seal.

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #s: a) 19242028, Exp. 04/30/2026; b) 19242028, Exp. 04/30/2026; c) 19242028, Exp. 04/30/2026

Quantity recalled: 11,568 tubes

Details

Product
Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for Use in Eyes, Rx Only, a) 30 gm Tube, NDC 68462-0455-35; b) 45 gm Tube, NDC 68462-0455-47; c) 100 gm Tube, NDC 68462-0455-94, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.
Recalling company
Glenmark Pharms
Classification
Class III
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the US.
Initiated
Sep 30, 2024
FDA report date
Oct 9, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Ciclopirox Gel 0.77% recalled?
Glenmark Pharmaceuticals Inc., USA recalled Ciclopirox Gel 0.77% in Sep 2024 — an FDA Class III recall (D-0002-2025) because Defective Container: Firm received complaints of broken tube at the seal. Unlikely to cause harm but violates FDA labeling or manufacturing regulations.
Why was Ciclopirox Gel 0.77% recalled?
Per the FDA enforcement record, the reason for recall D-0002-2025 was: Defective Container: Firm received complaints of broken tube at the seal.
Is a recalled Ciclopirox Gel 0.77% dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Unlikely to cause harm but violates FDA labeling or manufacturing regulations. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Ciclopirox Gel 0.77% are affected?
Distributed: Nationwide in the US.. The recall covers these lots — Lot #s: a) 19242028, Exp. 04/30/2026; b) 19242028, Exp. 04/30/2026; c) 19242028, Exp. 04/30/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0002-2025.

Source: openFDA Drug Enforcement record D-0002-2025

← All drug recalls